Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Samsung Biologics Co.,Ltd.
  6. News
  7. Summary
    A207940   KR7207940008

SAMSUNG BIOLOGICS CO.,LTD.

(A207940)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Samsung Biologics, GreenLight Biosciences Enter Deal to Produce COVID-19 mRNA Vaccines

11/29/2021 | 04:55am EST


ę MT Newswires 2021
All news about SAMSUNG BIOLOGICS CO.,LTD.
01/18S.Korea stocks hit 7-week closing low ahead of LGES IPO
RE
01/18SAMSUNG BIOLOGICS : Prior Notice on Disclosure of Final Earnings
PU
01/14South Korean Stocks Fall for Second Day as Bank of Korea Raises Base Rate; Samsung Biol..
MT
01/13Samsung Biologics to Start Building Fifth Plant to Meet Higher Biopharmaceutical Produc..
MT
01/13S.Korean stocks end lower on options expiry; BOK in focus
RE
01/12South Korean Stocks Jump After US Fed Chief’s Less Hawkish Testimony; Hanmi Pharm..
MT
01/12S.Korean stocks post best day in 6 weeks on Powell remarks
RE
01/03S.Korea stocks begin 2022 with mild gains on trade data boost
RE
2021Wall Street closes down, indexes still poised for big annual gains
RE
2021Samsung BioLogics says report on Biogen deal talks untrue
RE
More news
Analyst Recommendations on SAMSUNG BIOLOGICS CO.,LTD.
More recommendations
Financials
Sales 2021 1 554 B 1,30 B 1,30 B
Net income 2021 437 B 0,37 B 0,37 B
Net Debt 2021 242 B 0,20 B 0,20 B
P/E ratio 2021 123x
Yield 2021 -
Capitalization 53 991 B 45 408 M 45 298 M
EV / Sales 2021 34,9x
EV / Sales 2022 30,1x
Nbr of Employees 2 886
Free-Float 25,0%
Chart SAMSUNG BIOLOGICS CO.,LTD.
Duration : Period :
Samsung Biologics Co.,Ltd. Technical Analysis Chart | A207940 | KR7207940008 | MarketScreener
Technical analysis trends SAMSUNG BIOLOGICS CO.,LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 816 000,00 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
John Chongbo Rim President, Chief Executive Officer & Director
Tae-Han Kim Chairman
Yong-Ho An Managing Director & Head-Process Technology
Hyung-Woo Moon Head-Compliance Support
Seok-Woo Jung Independent Director
Sector and Competitors